Circulating Messenger RNA of α-Fetoprotein

Authors:

Abstract
Quiz Ref ID Hepatocelluar carcinoma (HCC) ranks fifth among malignancies worldwide and results in nearly 1 million deaths annually.1 Quiz Ref ID It is the leading cause of death in Taiwan.2,3 It is also one of the most common malignancies worldwide. After curative resection of HCC, tumors recur in about 70% of patients, usually within the first 3 years.2-4 In addition, the 3-year recurrence after liver transplantation for small HCC is still as high as 25%.5 By the time the recurrence of HCC is detected by the current imaging studies, aggressive treatment is frequently futile either because of extensive recurrence in the liver or distant metastasis. The high recurrence rate after resection or even transplantation is the most important limit of long-term survival. The challenge is to more accurately stage the disease early so that the most effective treatment strategy can be chosen to prolong the disease-free survival.

This publication has 19 references indexed in Scilit: